Dan Theodorescu, MD, PhD, and Richard Schulick, MD, MBA, are featured.

graphic

Dan Theodorescu, MD, PhD, started his position as director of the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center in Los Angeles, CA, on July 1. He previously served as director of the University of Colorado Cancer Center in Aurora, where he was also a professor of surgery and pharmacology. Theodorescu is the founding co–editor-in-chief of Bladder Cancer and is a member of the editorial board of Cancer Research. In addition, he serves on the National Cancer Policy Forum of the National Academies. Theodorescu has studied the molecular mechanisms underlying bladder cancer, discovering genes that regulate tumor growth and metastasis.

graphic

With Theodorescu's departure, Richard Schulick, MD, MBA, became director of the University of Colorado Cancer Center on July 1. He will continue to serve as the chair of the department of surgery at the University of Colorado School of Medicine. Previously, he was chief of the division of surgical oncology; a professor of surgery, oncology, and obstetrics and gynecology; and director of the pancreas cancer program at Johns Hopkins University in Baltimore, MD. Schulick has authored more than 300 publications and is the principal investigator on several clinical trials.